Patent | Date |
---|
Polymorphic mixture of Rifaximin and its use for the preparation of solid formulations Grant 10,745,415 - Grisenti , et al. A | 2020-08-18 |
Polymorphic mixture of Rifaximin and its use for the preparation of solid formulations Grant 10,556,915 - Grisenti , et al. Feb | 2020-02-11 |
Polymorphic Mixture Of Rifaximin And Its Use For The Preparation Of Solid Formulations App 20200002356 - Grisenti; Paride ;   et al. | 2020-01-02 |
Polymorphic Mixture Of Rifaximin And Its Use For The Preparation Of Solid Formulations App 20200002357 - Grisenti; Paride ;   et al. | 2020-01-02 |
Process for the preparation of aminoaryl- and aminoheteroaryl boronic acids and esters Grant 10,196,406 - Nonnenmacher , et al. Fe | 2019-02-05 |
Stable solid forms of regadenoson Grant 10,144,756 - Grisenti , et al. De | 2018-12-04 |
Process For The Preparation Of Aminoaryl- And Aminoheteroaryl Boronic Acids And Esters App 20170305937 - Nonnenmacher; Michael ;   et al. | 2017-10-26 |
Crystalline form of tiotropium bromide with lactose Grant 9,765,082 - Grisenti , et al. September 19, 2 | 2017-09-19 |
Process for the preparation of aminoaryl- and aminoheteroaryl boronic acids and esters Grant 9,738,663 - Nonnenmacher , et al. August 22, 2 | 2017-08-22 |
Biocatalyzed synthesis of the optically pure (R) and (S) 3-methyl-1,2,3,4-tetrahydroquinoline and their use as chiral synthons for the preparation of the antithrombic (21R)- and (21S)-argatroban Grant 9,630,923 - Grisenti April 25, 2 | 2017-04-25 |
Crystalline Form Of Tiotropium Bromide With Lactose App 20170044176 - Grisenti; Paride ;   et al. | 2017-02-16 |
Polymorphic Mixture Of Rifaximin And Its Use For The Preparation Of Solid Formulations App 20170015682 - Grisenti; Paride ;   et al. | 2017-01-19 |
Process for preparing fexofenadine Grant 9,403,770 - Bertolini , et al. August 2, 2 | 2016-08-02 |
Biocatalyzed synthesis of the optically pure (R) and (S) 3-methyl-1,2,3,4-tetrahydroquinoline and their use as chiral synthons for the preparation of the antithrombic (21R)- and (21S)-argatroban App 20160122303 - Grisenti; Paride | 2016-05-05 |
Process For The Preparation Of Aminoaryl- And Aminoheteroaryl Boronic Acids And Esters App 20160075723 - Nonnenmacher; Michael ;   et al. | 2016-03-17 |
Stable Solid Forms Of Regadenoson App 20160024137 - Grisenti; Paride ;   et al. | 2016-01-28 |
Water-soluble solid pharmaceutical inclusion complexes and their aqueous solutions for oral, ophthalmic, topical or parenteral use containing a macrolide and certain cyclodextrins Grant 9,169,269 - Mangia , et al. October 27, 2 | 2015-10-27 |
Process for the preparation of lacosamide Grant 8,796,488 - Bologna , et al. August 5, 2 | 2014-08-05 |
Process for the synthesis of tapentadol and intermediates thereof Grant 8,791,287 - Motta , et al. July 29, 2 | 2014-07-29 |
Chemo-enzymatic approach to the synthesis of pimecrolimus Grant 8,778,636 - Grisenti , et al. July 15, 2 | 2014-07-15 |
Process for the preparation of tapentadol and intermediates thereof Grant 8,729,308 - Motta , et al. May 20, 2 | 2014-05-20 |
Process For The Synthesis Of Tapentadol And Intermediates Thereof App 20130178644 - Motta; Giuseppe ;   et al. | 2013-07-11 |
Process For The Preparation Of Lacosamide App 20130030216 - Bologna; Alberto ;   et al. | 2013-01-31 |
17-alpha-substituted derivatives of estradiol with wound-healing activity Grant 8,357,675 - Ashcroft , et al. January 22, 2 | 2013-01-22 |
Process For The Preparation Of Tapentadol And Intermediates Thereof App 20120232306 - Motta; Giuseppe ;   et al. | 2012-09-13 |
Process for the preparation of 2-fluoroadenine Grant 8,202,991 - Saischek June 19, 2 | 2012-06-19 |
Water-soluble Solid Pharmaceutical Inclusion Complexes And Their Aqueous Solutions For Oral, Ophthalmic, Topical Or Parenteral Use Containing A Macrolide And Certain Cyclodextrins App 20120053198 - Mangia; Alberto ;   et al. | 2012-03-01 |
17-alpha-substituted Derivatives Of Estradiol With Wound-healing Activity App 20100035796 - Ashcroft; Gillian ;   et al. | 2010-02-11 |